Alaunos Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Alaunos Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q2 2024.
  • Alaunos Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 1.6M shares, a 0.16% increase year-over-year.
  • Alaunos Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 16M shares, a 10.5% increase from 2022.
  • Alaunos Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 14.5M shares, a 93.2% decline from 2021.
  • Alaunos Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 214M shares, a 2.27% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 1.6M +2.6K +0.16% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 16M +33.9K +0.21% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 16M +1.52M +10.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 240M +24.9M +11.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 1.6M -213M -99.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 16M -199M -92.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 14.5M Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 215M +557K +0.26% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 215M +572K +0.27% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 215M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q3 2021 215M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 214M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q3 2012 78.7M +10.6M +15.5% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-08
Q2 2012 78.5M +11.3M +16.8% Apr 1, 2012 Jun 30, 2012 10-Q/A 2012-08-28
Q3 2011 68.1M +20.7M +43.6% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 67.2M +24.9M +58.7% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-08-28
Q3 2010 47.4M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-03
Q2 2010 42.4M Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.